Details
Stereochemistry | ACHIRAL |
Molecular Formula | C14H12 |
Molecular Weight | 180.2451 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C1=CC=C(C=C1)\C=C\C2=CC=CC=C2
InChI
InChIKey=PJANXHGTPQOBST-VAWYXSNFSA-N
InChI=1S/C14H12/c1-3-7-13(8-4-1)11-12-14-9-5-2-6-10-14/h1-12H/b12-11+
Molecular Formula | C14H12 |
Molecular Weight | 180.2451 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
3,4',5-Trihydroxy-trans-stilbene (resveratrol) inhibits human cytomegalovirus replication and virus-induced cellular signaling. | 2004 Aug |
|
Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods. | 2006 Nov |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 03:22:26 GMT 2023
by
admin
on
Sat Dec 16 03:22:26 GMT 2023
|
Record UNII |
3FA7NW80A0
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
638088
Created by
admin on Sat Dec 16 03:22:26 GMT 2023 , Edited by admin on Sat Dec 16 03:22:26 GMT 2023
|
PRIMARY | |||
|
203-098-5
Created by
admin on Sat Dec 16 03:22:26 GMT 2023 , Edited by admin on Sat Dec 16 03:22:26 GMT 2023
|
PRIMARY | |||
|
5020
Created by
admin on Sat Dec 16 03:22:26 GMT 2023 , Edited by admin on Sat Dec 16 03:22:26 GMT 2023
|
PRIMARY | |||
|
(E)-Stilbene
Created by
admin on Sat Dec 16 03:22:26 GMT 2023 , Edited by admin on Sat Dec 16 03:22:26 GMT 2023
|
PRIMARY | |||
|
3FA7NW80A0
Created by
admin on Sat Dec 16 03:22:26 GMT 2023 , Edited by admin on Sat Dec 16 03:22:26 GMT 2023
|
PRIMARY | |||
|
2069
Created by
admin on Sat Dec 16 03:22:26 GMT 2023 , Edited by admin on Sat Dec 16 03:22:26 GMT 2023
|
PRIMARY | |||
|
m10216
Created by
admin on Sat Dec 16 03:22:26 GMT 2023 , Edited by admin on Sat Dec 16 03:22:26 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID4026050
Created by
admin on Sat Dec 16 03:22:26 GMT 2023 , Edited by admin on Sat Dec 16 03:22:26 GMT 2023
|
PRIMARY | |||
|
36007
Created by
admin on Sat Dec 16 03:22:26 GMT 2023 , Edited by admin on Sat Dec 16 03:22:26 GMT 2023
|
PRIMARY | |||
|
103-30-0
Created by
admin on Sat Dec 16 03:22:26 GMT 2023 , Edited by admin on Sat Dec 16 03:22:26 GMT 2023
|
PRIMARY |